Log in to search using one of your social media accounts:

 

conjugated equine estrogens and medroxyprogesterone acetate, Prempro, Premphase
Title: conjugated equine estrogens and medroxyprogesterone acetate, Prempro, PremphaseCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 8/7/2017 12:00:00 AM (Source: MedicineNet Menopause General)
Source: MedicineNet Menopause General - August 7, 2017 Category: Primary Care Source Type: news

Debate Roils India Over Family Planning Method
A family in New Delhi. Given India's high infant mortality rate, one of the highest in the world, many women are not keen on sterilisation since they feel that it shuts out their option of having children later if required. Credit: Neeta Lal/IPSBy Neeta LalNEW DELHI, Nov 29 2016 (IPS)The Indian government’s decision to make injectable contraceptives available to the public for free under the national family planning programme (FPP) has stirred debate about women’s choices in the world’s largest democracy and second most populous country.The controversial contraceptive containing the drug Depot Medroxyprog...
Source: IPS Inter Press Service - Health - November 29, 2016 Category: Global & Universal Authors: Neeta Lal Tags: Asia-Pacific Headlines Health Population Women's Health Contraception Family Planning India sterilization Source Type: news

Provera (Medroxyprogesterone Acetate Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 12, 2016 Category: Drugs & Pharmacology Source Type: news

Birth Control Options for Women Over 40
Gillian Dean, MD, MPH Associate Professor of Obstetrics, Gynecology and Reproductive Science Icahn School of Medicine at Mount Sinai The Mount Sinai Hospital Birth Control Options for Women Over 40 Many women believe, once they pass 40, that they are no longer fertile. In fact, a woman can get pregnant, intentionally or not, into her late 40s and beyond. And pregnancy after age 40 may carry greater risks. For this reason, contraception until menopause is important for women who are at risk for pregnancy and don't want to be pregnant. Because of misconceptions about the health risks of different birth control methods, ...
Source: Healthy Living - The Huffington Post - August 24, 2016 Category: Consumer Health News Source Type: news

Depo-Provera (Medroxyprogesterone) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 28, 2016 Category: Drugs & Pharmacology Source Type: news

Contraceptive ring, implant, and DMPA tied to lower sexual interest
Compared with women using copper IUDs, women using depot medroxyprogesterone acetate, the contraceptive ring, and the implant were more likely to report a lack of interest in sex in a survey. Women... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - February 18, 2016 Category: Endocrinology Source Type: news

Adolescent weight gain on popular injectable contraceptive may depend on micronutrient intake
Since its introduction nearly 23 years ago, the popular injectable contraceptive depot medroxyprogesterone acetate (DMPA) has been associated with causing substantial weight gain in some adolescent girls. Without being able to identify or predict which girls will gain weight on the drug, physicians typically counsel all teens receiving DMPA to simply eat less. New research suggests that the message may need to change to “eat better.” (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 2, 2016 Category: Science Source Type: news

Medroxyprogesterone Use Associated With Repeat Abortions Medroxyprogesterone Use Associated With Repeat Abortions
Medroxyprogesterone may not be an effective form of contraception for women who are at risk for repeat abortions. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 15, 2015 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

A case of frontotemporal dementia presenting with treatment-refractory psychosis and extreme violence: response to combination of clozapine, medroxyprogesterone, and sertraline - Jha MK, Lambert ES, Beadles BA, Spradling B, Martinez R, Renfro N, Byerly M.
[Abstract unavailable] Language: en... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - October 23, 2015 Category: Global & Universal Tags: Age: Elder Adults Source Type: news

Pfizer launches Sayana Press self-injectable contraceptive in UK
Pfizer has launched a self-injectable contraceptive called Sayana Press (medroxyprogesterone acetate) for women in the UK. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 24, 2015 Category: Pharmaceuticals Source Type: news

Why do certain hormonal contraceptives increase the risk of HIV?
In recent years, evidence has been building that injectable contraceptive depot medroxyprogesterone acetate (Depo-Provera or DMPA) is associated with an increased risk of HIV infection. Now a study provides a biological explanation for the phenomenon. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 1, 2015 Category: Science Source Type: news

Provera (Medroxyprogesterone Acetate Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 26, 2015 Category: Drugs & Pharmacology Source Type: news

Contraceptive and cholesterol-lowering drugs used to treat cancer
(University of Birmingham) The combination of a cholesterol-lowering drug, Bezafibrate, and a contraceptive steroid, Medroxyprogesterone Acetate, could be an effective, non-toxic treatment for a range of cancers, researchers at the University of Birmingham have found. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 14, 2015 Category: Cancer & Oncology Source Type: news

Depo-Provera (Medroxyprogesterone) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 11, 2015 Category: Drugs & Pharmacology Source Type: news

Risk of HIV infection in studies of African women using hormonal contraceptives
Use of the injectable progestin contraceptive depot-medroxyprogesterone acetate (DMPA) is linked to an increased risk for HIV infection, according to a new article. The researchers did not find a significantly increased risk for HIV infection in women who used a different injectable progestin, norethisterone enanthate (NET-EN), nor in those who used combined oral contraceptives (COC). (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 22, 2015 Category: Science Source Type: news

Risk of HIV infection in studies of African women using hormonal contraceptives
(PLOS) Use of the injectable progestin contraceptive depot-medroxyprogesterone acetate is linked to an increased risk for HIV infection, according to an article published by Charles Morrison of FHI 360 and colleagues in this week's PLOS Medicine. The researchers did not find a significantly increased risk for HIV infection in women who used a different injectable progestin, norethisterone enanthate, nor in those who used combined oral contraceptives. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - January 22, 2015 Category: Global & Universal Source Type: news

Does contraceptive jab make HIV more likely?
Conclusion This is a well-conducted systematic review that tried to identify all studies investigating the possible link between hormonal contraceptive use and HIV. It did not find an association between HIV risk and oral hormonal contraceptive use, nor with one type of injectable progestogen contraceptive. But it did find an increased risk of HIV in studies where women used a commonly used injectable form of contraception called depot medroxyprogesterone acetate. The review had strict inclusion criteria, but the possibility of selection bias and confounding from other factors still cannot be ruled out. Only three...
Source: NHS News Feed - January 12, 2015 Category: Consumer Health News Tags: Lifestyle/exercise Medication Source Type: news

Depo-Provera Linked to Increased HIV Risk in AfricaDepo-Provera Linked to Increased HIV Risk in Africa
A meta-analysis showed a link between depot medroxyprogesterone acetate use and increased relative risk for HIV infection among women in sub-Saharan Africa. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 9, 2015 Category: Consumer Health News Tags: HIV/AIDS News Source Type: news

Study supports link between injectable hormonal contraceptive and HIV risk
Women using depot medroxyprogesterone acetate, commonly known as Depo-Provera or the birth control shot, have a moderately increased risk of becoming infected with HIV, a large meta-analysis of 12 studies involving more than 39,500 women has found. Other forms of hormonal contraception, including oral contraceptive pills, do not appear to increase this risk. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 9, 2015 Category: Science Source Type: news

Meta-Analysis: Depot Medroxyprogesterone Acetate Linked to Increase in HIV Acquisition (FREE)
By Amy Orciari Herman Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS A new meta-analysis adds to evidence suggesting that depot medroxyprogesterone acetate (DMPA, marketed as Depo-Provera) is associated with increased risk for HIV acquisition. The findings appear in … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 9, 2015 Category: Primary Care Source Type: news

Nigeria: Ekeocha - Pfizer and Sterilization of African Women
[Guardian]AS I tried to catch up on the latest news on Africa, I stumbled upon the recent joint announcement of Pfizer Inc. the Bill & Melinda Gates Foundation and the Children's Investment Fund Foundation (CIFF) to expand access to Pfizer's injectable contraceptive, Sayana® Press (medroxyprogesterone acetate), for women in the world's poorest countries. Some of the targeted countries named for this expansive contraception project include Burkina Faso, Kenya, Niger, Senegal, Uganda and my own country, Nigeri (Source: AllAfrica News: Pregnancy and Childbirth)
Source: AllAfrica News: Pregnancy and Childbirth - December 15, 2014 Category: OBGYN Source Type: news

Pfizer agrees to supply contraceptive Sayana Press in poorer countries
US-based drugmaker Pfizer has signed an agreement with Bill & Melinda Gates Foundation and Children's Investment Fund Foundation (CIFF) to expand access to its injectable contraceptive, Sayana Press (medroxyprogesterone acetate), for women in poorer … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - November 14, 2014 Category: Pharmaceuticals Source Type: news

medroxyprogesterone, Provera, Depo-Provera, Depo-Sub Q Provera 104
Title: medroxyprogesterone, Provera, Depo-Provera, Depo-Sub Q Provera 104Category: MedicationsCreated: 5/21/1998 12:00:00 AMLast Editorial Review: 8/7/2014 12:00:00 AM (Source: MedicineNet Menopause General)
Source: MedicineNet Menopause General - August 7, 2014 Category: Primary Care Source Type: news

medroxyprogesterone, Provera, Depo-Provera, Depo-Sub Q Provera 104
Title: medroxyprogesterone, Provera, Depo-Provera, Depo-Sub Q Provera 104Category: MedicationsCreated: 5/21/1998 12:00:00 AMLast Editorial Review: 8/7/2014 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 7, 2014 Category: Drugs & Pharmacology Source Type: news

Looking forward to the New Year (2014) – Lisa’s Story
Hi, I’m 50 yrs old. In 2010 I had a pelvic floor lift due to leaking urine when I laughed, coughed and did star jumps at the gym! My gynae decided he would replace my mirena coil at the same time. On having my coil checked later it could not be found, so I had a scan which showed multiple fibroids, small but plenty of them. I was assured that the coil would keep them at bay! Two months ago after suffering with lower back pain and constipation, I returned to the doctors I had felt a large tender lump, lower right of my abdomen. I had a scan a week later and discovered my fibroids were much larger, with one 7cm plus t...
Source: The Hysterectomy Association - December 5, 2013 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Your Stories cancer fibroids Source Type: news

Advice Conflicts on Hormone Protocols for TranssexualsAdvice Conflicts on Hormone Protocols for Transsexuals
Experts debate the risks and benefits of intramuscular or transdermal estrogen and the pros and cons of medroxyprogesterone vs leuprolide. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 3, 2013 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Subcutaneously delivered contraceptive launched by Pfizer
Sayana® Press (medroxyprogesterone acetate), the first subcutaneously delivered long-acting reversible contraceptive (LARC) has been launched by Pfizer. It is administered by a doctor or nurse, given under the skin into the thigh or abdomen every 13 weeks using a prefilled Uniject injection. (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 17, 2013 Category: Drugs & Pharmacology Source Type: news